ALTA2618

· Alterome Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ALTA2618, covering 2026-03-09 to 2026-03-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors [Phase 1]